Dr. Thulashie Sivarajah, MD

Dr. Sivarajah practices at Geisinger Wyoming Valley Medical Center in Plains Township, Pennsylvania.

Dr. Sivarajah's NPI, 1467700724, was assigned on August 16, 2012. Dr. Sivarajah holds Pennsylvania license MD460680.

Dr. Sivarajah's primary practice is Geisinger Wyoming Valley Medical Center, at 1000 E Mountain Dr, Plains Township, PA 18702 in Luzerne County. The practice phone is (570) 826-7300.

Dr. Sivarajah's primary practice is Geisinger Wyoming Valley Medical Center in Plains Township, Pennsylvania. Dr. Sivarajah is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger. Dmand AI also links Dr. Sivarajah to 2 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sivarajah practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Sivarajah's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Sivarajah is licensed in Pennsylvania.

CMS data shows 438 Medicare services from Dr. Sivarajah across 7 procedure codes in 2024, for 277 Medicare patients. Medicare paid $44,167 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 277 Medicare patients who saw Dr. Sivarajah in 2024. The largest group is 75 to 84, with 96 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sivarajah's median patient age at 48, with 59% women.

In 2024, Dr. Sivarajah wrote 669 Medicare Part D claims for 155 patients. 66% of them were for generic drugs. CMS names the drug for 498 of them, across 17 drugs with 11 or more claims each, at $599,928 in total drug cost. In 2023, CMS named 324 claims across 12 drugs.

Dr. Sivarajah accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sivarajah as offering telehealth.

Dmand AI links 2 papers to Dr. Sivarajah, published from 2016 to 2017. Dr. Sivarajah's most frequent co-authors are Burke A. Cunha, MD and Ismail Opeyemi Jimada, MD.

CMS Open Payments shows 9 general payments to Dr. Sivarajah from 4 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 100% of the total. Allergan Inc. paid the most, $91.